Monthly Archives: September 2026

Traditional pharmaceutical manufacturing has historically been associated with scale. Large batches are manufactured, tested and released for thousands or millions of patients. Precision medicine is helping to change that model. Some emerging therapies target increasingly defined patient populations. Others, particularly advanced therapies, may involve extremely small manufacturing campaigns or even patient-specific material. That shift

Efficiency and compliance are sometimes presented as competing priorities in pharmaceutical manufacturing. One side wants faster processes, less paperwork and lower costs. The other wants controls, documentation and assurance. That is an increasingly outdated way of looking at quality. A mature Pharmaceutical Quality System should be capable of improving efficiency while protecting patients and

Outsourcing has become an established part of modern pharmaceutical manufacturing. Drug developers may depend on Contract Manufacturing Organisations (CMOs), Contract Development and Manufacturing Organisations (CDMOs), testing laboratories, packaging specialists, logistics providers and raw-material suppliers spread across multiple countries. The advantages are significant. Outsourcing can provide specialist expertise, additional manufacturing capacity, access to advanced technologies

Electronic Quality Management Systems have become central to the way pharmaceutical organisations manage deviations, CAPAs, change controls, audits, training, documentation and other critical quality processes. Yet the more important an eQMS becomes to an organisation, the more complicated upgrading it can become. What may appear to be a straightforward software project can quickly become